Asia Pacific Gene Expression Market Report and Forecast 2024-2032

Asia Pacific Gene Expression Market Report and Forecast 2024-2032

Asia Pacific Gene Expression Market Report and Forecast 2024-2032

Asia Pacific Gene Expression Market Outlook

The global gene expression market size was valued at USD 13.3 billion in 2023, with Asia Pacific holding a significant market share. It is driven by the growing demand for personalized medicine in the region. The market is expected to grow at a CAGR of 12.7% during the forecast period of 2024-2032, with the values likely attain USD 32.4 billion by 2032.

Key Takeaways

• Growth in cancer incidence along with other chronic diseases wherein gene expression may contribute as an effective treatment alternative is a significant factor boosting the market growth.
• The Asia Pacific gene expression market share is propelled by increasing adoption of innovative technologies. Milner Therapeutics Institute (MTI) at the University of Cambridge and AstraZeneca partnered in November 2023, to understand the genomic relationship with chronic diseases by using technologies like CRISPR.
• The market value is driven by increasing incidence of collaborations and acquisitions to develop and implement best resources in the region. In May 2023, Pfizer, and Thermo Fisher Scientific Inc., collaborated to provide local access to NGS test for lung and breast cancer patients in over 30 countries.

Asia Pacific Gene Expression Market Analysis

Gene expression is a process by which information encoded in a gene is used in the synthesis of a functional gene product which enables to produce proteins or end products. It involves different processes such as gene transcription, translation, post-translational modification of protein and RNA splicing among others. Asia Pacific is accountable for 50% of the overall new cancer cases worldwide. The cancer associated mortality rate is likely to increase by 36% in the coming years. With a deeper understanding of human physiology and rising burden of chronic illnesses like cancer and other rare diseases, gene expression finds its application in multiple medical domains. Consequently, the Asia Pacific gene expression market demand has witness growth in recent years.

In May 2023, Thermo Fisher Scientific Inc. and Pfizer entered into a collaboration agreement with an aim to enhance the local access to next-generation sequencing (NGS) tests for breast and lung cancer patients across several countries. The initiative was specifically aimed at regions where advanced genomic testing had been unavailable or limited. The access to NGS testing provides quicker gene analysis, enabling healthcare providers to efficiently choose the appropriate treatments for the individual patient. The Asia Pacific gene expression market growth is fuelled by such initiatives.

Increasing incorporation of cutting-edge technologies to yield most effective results in disease management and treatment is one of the major market trends. In November 2023, AstraZeneca and University of Cambridge expanded functional genomics partnership. At the university, scientists engaged in the utilization of advanced CRISPR technology to understand the genetic mechanisms better. This can lead to the development of effective treatment for multiple diseases including severe respiratory, cardiovascular, and metabolic diseases.

One of the significant Asia Pacific gene expression market trends include increased healthcare expenditure and investments to meet the rising demand for molecular diagnostics and personalized medicine. The expansion of health and pharmaceutical industry in emerging economies such as India, South Korea and Singapore has led to a greater demand for gene expression profiling. This can be attributed to increased incidence of drug discovery and development processes, which includes target identification, biomarker discovery, and preclinical studies.

Asia Pacific Gene Expression Market Segmentation  

Market Breakup by Process

• Sample Collection
• Purification
• cDNA synthesis and Conversion
• PCR Analysis
• Data Analysis and Interpretation

Market Breakup by Application

• Clinical Diagnostics
• Drug Discovery and Development
• Research Activities
• Other Applications

Market Breakup by Technique

• RNA Expression
• Promoter Analysis
• Protein Expression and Posttranslational Modification Analysis

Market Breakup by Product

• Consumables
• Instruments
• Service

Market Breakup by End User

• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
• Academic Research Centres

Market Breakup by Countries

• Japan
• India
• ASEAN
• Australia
• Others

Asia Pacific Gene Expression Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• F. Hoffmann-La Roche Ltd
• QIAGEN
• Oxford Gene Technology (OGT) Group
• Eurofins Scientific
• LGC Limited
• Promega Corporation
• Takara Bio Inc.
• PacBio
• Smith & Nephew plc
• Abbott

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

FAQs

• What is the Asia Pacific gene expression market forecast outlook for 2024-2032?

The Asia Pacific gene expression market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 10.4% during the forecast period of 2024-2032 and is likely to reach a market value of USD 32.4 billion by 2032.

• What are the major factors aiding the Asia Pacific gene expression market demand?

Increasing investment in genomics and biotechnology, and expansion of personalized medicine, are fuelling the demand for the market.

• What are the major factors aiding the Asia Pacific gene expression market trends?

Major market trends include increasing incidence of mergers and collaborations amonsgst key healthcare companies. For instance, in May 2023, Thermo Fisher Scientific Inc., and Pfizer entered into a collaboration agreement to enhance the local access to next-generation sequencing (NGS) tests for breast and lung cancer patients across several countries.

• What is the market segmentation based on process?

Based on the process, the market is segmented into sample collection, purification, cDNA synthesis and conversion, PCR analysis, data analysis and interpretation.

• What is the market breakup by application?

By application, the market is divided into clinical diagnostics, drug discovery and development, research activities, and others.

• What is the market segmentation based on technique?

The market breakup by technique includes RNA expression, promoter analysis, protein expression and posttranslational modification analysis.

• What are the major end users of gene expression market?

End users of the market are pharmaceutical and biotechnology companies, diagnostic laboratories, academic research centres.

• What is the market segmentation by countries?

The market segmentation by countries includes Japan, India, ASEAN, Australia and others

• Who are the key players involved in the Asia Pacific gene expression market?

The key players in the market are F. Hoffmann-La Roche Ltd, QIAGEN, Oxford Gene Technology (OGT) Group, Eurofins Scientific, LGC Limited, Promega Corporation, Takara Bio Inc., PacBio, Smith & Nephew plc, and Abbott.

Meta description

The Asia Pacific gene expression market size is impacted by the increasing demand in the global market, which was valued at USD 13.3 billion in 2023 and it is anticipated to grow at a CAGR of 10.4% during the forecast period of 2024-2032.

*Please Note:* The report will take 7 business days to complete, after order confirmation.